
- Psychedelic-assisted therapy
- Personalized dosing protocols
- Integration of technology
Psychedelic-assisted therapy
In 2024, micro-dosing with psychedelics such as psilocybin and LSD is gaining traction as a therapeutic approach for mental health conditions. Research suggests that sub-perceptual doses of these substances can alleviate symptoms of depression, anxiety, and PTSD, while also promoting overall well-being.
Personalized dosing protocols
Healthcare providers are increasingly tailoring micro-dosing regimens to individual needs, taking into account factors such as body weight, metabolism, and specific health conditions. This personalized approach aims to maximize therapeutic benefits while minimizing potential risks and side effects.
Integration of technology
Advancements in digital health tools are being utilized to track and monitor the effects of micro-dosing therapy on patients. Wearable devices and mobile apps are used to collect real-time data on mood, sleep patterns, and cognitive function, allowing for more precise adjustments to dosing protocols and treatment plans.